Combined liver-kidney transplantation in patients with cirrhosis and chronic kidney disease
Open Access
- 4 February 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 25 (7) , 2356-2363
Abstract
The outcome of patients with cirrhosis and chronic kidney disease treated with combined liver–kidney transplantation (CLKT) is not well known because most series of patients treated with CLKT include not only patients with cirrhosis but also patients with inherited diseases without cirrhosis. To evaluate to what extent the combined kidney transplantation impairs posttransplantation outcome compared to liver transplantation (LT) alone, the outcome of patients with cirrhosis and chronic kidney disease treated with CLKT (n = 20) was compared to that of a group of patients with cirrhosis without chronic kidney disease treated with LT alone matched by age, sex, year of transplantation and severity of cirrhosis (n = 60). The primary end point of the study was survival, and secondary end points were outcome of renal function and complications within 6 months of transplantation. Patients with CLKT had a higher incidence of bacterial infections and transfusion requirements compared to LT patients. The incidence of acute renal failure during the first 6 months was similar, yet the severity of renal failure was greater in patients with CLKT. Hospital and intensive care unit (ICU) stays were longer in the CLKT group. One- and three-year survival probabilities in patients treated with CLKT were 80 and 75% compared to 97 and 88%, respectively, in patients treated with LT. In conclusion, CLKT for patients with cirrhosis and chronic kidney disease is associated with a relatively high frequency of postoperative complications that moderately impairs short-term survival. However, 3-year survival of patients with cirrhosis treated with CLKT is excellent.Keywords
This publication has 34 references indexed in Scilit:
- Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized StudyGastroenterology, 2008
- A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin for Type 1 Hepatorenal SyndromeGastroenterology, 2008
- Declining Outcomes in Simultaneous Liver-Kidney Transplantation in the MELD Era: Ineffective Usage of Renal AllograftsTransplantation, 2008
- Results of combined and sequential liver-kidney transplantationLiver Transplantation, 2003
- Analysis of the United Network for Organ Sharing database comparing renal allografts and patient survival in combined liver-kidney transplantation with the contralateral allografts in kidney alone or kidney-pancreas transplantation1Transplantation, 2003
- Prolongation of long-term kidney graft survival by a simultaneous liver transplant: the liver does it, and the heart does it tooTransplantation, 2002
- Identification of patients best suited for combined liver-kidney transplantation: Part IILiver Transplantation, 2002
- COMBINED LIVER-KIDNEY TRANSPLANTATION: WHAT ARE THE INDICATIONS?Transplantation, 1997
- THE LIVER NEITHER PROTECTS THE KIDNEY FROM REJECTION NOR IMPROVES KIDNEY GRAFT SURVIVAL AFTER COMBINED LIVER AND KIDNEY TRANSPLANTATION FROM THE SAME DONOR1Transplantation, 1996
- LONG-TERM SURVIVAL AND RENAL FUNCTION FOLLOWING LIVER TRANSPLANTATION IN PATIENTS WITH AND WITHOUT HEPATORENAL SYNDROMETransplantation, 1991